Skip to main content
OpenTrials

Clinical trial condition

Multiple Sclerosis

Explore clinical trials studying Multiple Sclerosis. Study availability and eligibility vary by location and protocol.

291 public trials 23 recruiting studies
Refine in advanced search Browse all conditions

Multiple Sclerosis trial results

Completed

Efficacy and Safety of BIIB019 (Daclizumab High Yield Process) Versus Interferon β 1a in Participants With Relapsing-Remitting Multiple Sclerosis

NCT01064401

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +6 more
Locations
  • Research Site Gilbert, Arizona, United States
  • Research Site Phoenix, Arizona, United States
  • Research Site Tucson, Arizona, United States
  • Research Site Little Rock, Arkansas, United States
View all 228 locations
View Trial Details
Completed

PK and PD Study of Natalizumab in Pediatric Subjects With RRMS

NCT01884935

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +6 more
Locations
  • Research Site Cefalù, Italy
  • Research Site Gallarate, Italy
  • Research Site Milan, Italy
  • Research Site Padua, Italy
View Trial Details
Completed

Management Of The Infusion-Associated Reactions In RRMS Patients Treated With LEMTRADA

NCT02205489

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +6 more
Locations
  • Investigational Site Number 056002 Bruges, Belgium
  • Investigational Site Number 056001 Brussels, Belgium
  • Investigational Site Number 250009 Dijon, France
  • Investigational Site Number 250005 Lille, France
View all 20 locations
View Trial Details
Completed

Real-world Outcomes on Tecfidera (BG00012, Dimethyl Fumarate) Post-Tysabri (BG00002, Natalizumab)

NCT02159573

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +6 more
Locations
  • Research Site Birmingham, Alabama, United States
  • Research Site Cullman, Alabama, United States
  • Research Site Gilbert, Arizona, United States
  • Research Site Phoenix, Arizona, United States
View all 43 locations
View Trial Details
Completed

Immune Globulin Intravenous (IGIV) To Treat Relapsing, Remitting Multiple Sclerosis

NCT00220779

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +5 more
Locations
  • Barrow Neurological Institute at St. Joseph's Hospital and Medical Center Phoenix, Arizona, United States
  • Northwest NeuroSpecialists, PLLC Tucson, Arizona, United States
  • The Mt. Sinai Medical Center, Department of Neurology New York, United States
  • SUNY Health Science Center at Stony Brook, Department of Neurology Stony Brook, New York, United States
View all 37 locations
View Trial Details
Completed

Extension Study of MT-1303

NCT01890655

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +6 more
Locations
  • Research Site City Name, Belgium
  • Research Site City Name, Bulgaria
  • Research Site City Name, Canada
  • Research Site City Name, Croatia
View all 17 locations
View Trial Details

Related conditions